Two-Trace Two-Dimensional Correlation Analysis for the Confirmation of Therapeutic Protein Identification and Evaluation of Extent of Glycosylation: A Rapid Method for Testing Critical Quality Attributes
- 1Protein Dynamic Solutions, Inc., 105 Road km 0.8 Monacillo Ward, San Juan, PR 00927, USA
- 2Manatus Bio, LLC. Guaynabo, Puerto Rico 00966, USA
Abstract
Therapeutic proteins are an effective and highly selective, yet complex class of drugs for the treatment of diseases to improve the quality of life of patients. Their manufacturability is subject to evaluation to ensure product quality, safety, and efficacy. To this end, a need exists within the biopharmaceutical industry for a streamlined platform method that allows end-to-end therapeutic protein comparability assessment of multiple critical quality attributes. The implementation of a single platform method would de-risk development and accelerate speed to market. Herein, a novel method for therapeutic protein identification has been proposed that can be used to monitor regulated drug products throughout their lifecycle. The innovative streamlined method evaluates the intact protein in its formulation conditions. This breakthrough technology comprises a quantum cascade laser microscope with a heated accessory, an innovative slide cell array with a fixed path-length that allows for experimental flexibility and quantitative analysis, and dedicated software. Two-trace two-dimensional correlation spectroscopy (2T2D) was proven useful for the determination of spectral differences between two samples. The weighted absorbance differences, defined using the correlation between the cross-peaks, can be used to determine substantial molecular information, including secondary structure, the extent of glycosylation, amino acid content, and solvent accessibility, which is directly related to the therapeutic protein’s critical quality attributes. Four different comparability assessments are discussed to demonstrate the usefulness of the platform method for the confirmation of protein identification and the comprehensive evaluation of the extent of glycosylation.
Related
- Identification of Glycosylation-Associated Proteins in Colostrum: A Review of Mass Spectrometry-Based Strategies.
- Identification of a Glycosylation‐Related Gene Prognostic Signature for Non–Small Cell Lung Cancer
- Genome-wide identification of UDP-glycosyltransferase gene family in Dendrobium huoshanense and functional characterization of DhUGT44 mediating flavonoid 7-O-glycosylation and cold tolerance
- A genome-wide computational approach for therapeutic targets identification and synthetic peptide assembly enable rational vaccine design against Arcanobacterium haemolyticum
- Structural identification of the RY12 domain of RyR1 as an ADP sensor and the target of the malignant hyperthermia therapeutic dantrolene.
BibTeX
@article{pastrana2026twotrace,
title = {{Two-Trace Two-Dimensional Correlation Analysis for the Confirmation of Therapeutic Protein Identification and Evaluation of Extent of Glycosylation: A Rapid Method for Testing Critical Quality Attributes}},
author = {Belinda Pastrana and Sherly Nieves and Eduardo I. Canto},
journal = {Applied Spectroscopy},
year = {2026},
month = may,
doi = {10.1177/00037028261451288},
url = {https://doi.org/10.1177/00037028261451288},
note = {CC BY-NC 4.0},
}
RIS
TY - JOUR
TI - Two-Trace Two-Dimensional Correlation Analysis for the Confirmation of Therapeutic Protein Identification and Evaluation of Extent of Glycosylation: A Rapid Method for Testing Critical Quality Attributes
AU - Belinda Pastrana
AU - Sherly Nieves
AU - Eduardo I. Canto
PY - 2026
DA - 2026/05/18
JO - Applied Spectroscopy
DO - 10.1177/00037028261451288
UR - https://doi.org/10.1177/00037028261451288
AB - Therapeutic proteins are an effective and highly selective, yet complex class of drugs for the treatment of diseases to improve the quality of life of patients. Their manufacturability is subject to evaluation to ensure product quality, safety, and efficacy. To this end, a need exists within the biopharmaceutical industry for a streamlined platform method that allows end-to-end therapeutic protein comparability assessment of multiple critical quality attributes. The implementation of a single platform method would de-risk development and accelerate speed to market. Herein, a novel method for therapeutic protein identification has been proposed that can be used to monitor regulated drug products throughout their lifecycle. The innovative streamlined method evaluates the intact protein in its formulation conditions. This breakthrough technology comprises a quantum cascade laser microscope with a heated accessory, an innovative slide cell array with a fixed path-length that allows for experimental flexibility and quantitative analysis, and dedicated software. Two-trace two-dimensional correlation spectroscopy (2T2D) was proven useful for the determination of spectral differences between two samples. The weighted absorbance differences, defined using the correlation between the cross-peaks, can be used to determine substantial molecular information, including secondary structure, the extent of glycosylation, amino acid content, and solvent accessibility, which is directly related to the therapeutic protein’s critical quality attributes. Four different comparability assessments are discussed to demonstrate the usefulness of the platform method for the confirmation of protein identification and the comprehensive evaluation of the extent of glycosylation.
SN - 0003-7028
SN - 1943-3530
ER -